HCPCS Code Descriptor:
Injection, treprostinil, 1 mg
66302-0101-01, 66302-0102-01, 66302-0110-01, 66302-0105-01, 43598-0648-11, 43598-0649-11, 43598-0647-11, 43598-0646-11, 42023-0208-01, 42023-0209-01, 42023-0207-01, 42023-0206-01, 00781-3427-80, 00781-3430-80, 00781-3425-80, 00781-3420-80, 00703-0696-01, 00703-0686-01, 00703-0676-01, 00703-0666-01
Route of Administration:
REMODULIN is a Cardiology drug manufactured by United Therapeutics and administered via the Injection route of administration. The J Code: J3285 is aligned to the drug REMODULIN.
Remodulin belongs to the group of medications known as vasodilators. Remodulin works by dilating the blood vessels in the lungs and helps to mitigate the symptoms of high blood pressure. Remodulin is administered via subcutaneous infusion or an intravenous infusion. Remodulin is a generic drug that is manufactured by Sicor Pharmaceuticals, Sandoz, and Par Pharmaceutical Incorporated. Patient assistance programs for this medication can be found through United Therapeutics.